A Rac1/Cdc42 GTPase-Specific Small Molecule Inhibitor Suppresses Growth of Primary Human Prostate Cancer Xenografts and Prolongs Survival in MiceKarin Zins, Seyedhossein Aharinejad|PLoS ONE|2013Cited by 95
Targeting Cdc42 with the small molecule drug AZA197 suppresses primary colon cancer growth and prolongs survival in a preclinical mouse xenograft model by downregulation of PAK1 activityKarin Zins, Seyedhossein Aharinejad|Journal of Translational Medicine|2013Cited by 67
Differential prognostic impact of interleukin-34 mRNA expression and infiltrating immune cell composition in intrinsic breast cancer subtypesKarin Zins, Dietmar Abraham|Oncotarget|2018Cited by 36